Table 4.
Frailty aspect | Group | Multiclass SBS (95% CI) | Negative class SBS (95% CI) | Neutral class SBS (95% CI) | Positive class SBS (95% CI) |
---|---|---|---|---|---|
Respiratory impairment | White | 0.57 (0.56–0.59) | 0.60 (0.59–0.62) | 0.54 (0.52–0.56) | 0.56 (0.53–0.59) |
Nonwhite | 0.54 (0.52–0.57) | 0.57 (0.55–0.59) | 0.51 (0.48–0.53) | 0.54 (0.5–0.59) | |
Male | 0.57 (0.55–0.59) | 0.60 (0.57–0.62) | 0.55 (0.52–0.57) | 0.54 (0.5–0.58) | |
Female | 0.56 (0.54–0.58) | 0.59 (0.57–0.61) | 0.51 (0.48–0.54) | 0.56 (0.53–0.59) | |
Musculo-skeletal | White | 0.44 (0.41–0.47) | 0.46 (0.43–0.5) | 0.40 (0.36–0.45) | 0.43 (0.39–0.47) |
Problem | Nonwhite | 0.41 (0.38–0.44) | 0.44 (0.41–0.47) | 0.39 (0.35–0.43) | 0.37 (0.32–0.43) |
Male | 0.38 (0.35–0.42) | 0.41 (0.38–0.45) | 0.33 (0.28–0.38) | 0.41 (0.35–0.46) | |
Female | 0.45 (0.42–0.48) | 0.47 (0.45–0.5) | 0.43 (0.39–0.46) | 0.41 (0.37–0.45) | |
Fall risk | White | 0.53 (0.5–0.55) | 0.55 (0.52–0.58) | 0.32 (0.28–0.36) | 0.61 (0.58–0.65) |
Nonwhite | 0.43 (0.39–0.47) | 0.46 (0.42–0.5) | 0.19 (0.12–0.27) | 0.52 (0.48–0.57) | |
Male | 0.50 (0.47–0.54) | 0.53 (0.5–0.57) | 0.26 (0.19–0.33) | 0.60 (0.56–0.64) | |
Female | 0.49 (0.46–0.51) | 0.51 (0.48–0.53) | 0.29 (0.24–0.33) | 0.57 (0.54–0.6) | |
Nutritional deficiency | White | 0.64 (0.6–0.69) | 0.67 (0.63–0.72) | 0.14 (0.01–0.3) | 0.7 (0.66–0.75) |
Nonwhite | 0.49 (0.42–0.57) | 0.50 (0.43–0.59) | 0.10 (−0.05 to 0.3) | 0.59 (0.51–0.68) | |
Male | 0.66 (0.6–0.72) | 0.70 (0.65–0.75) | 0.37 (0.25–0.5) | 0.68 (0.61–0.75) | |
Female | 0.55 (0.5–0.6) | 0.57 (0.52–0.62) | −0.03 (−0.17 to 0.14) | 0.66 (0.61–0.72) |
Note: Each scaled Brier score is the macro average across all 4 frailty aspects. The multiclass scaled Brier score is our primary performance metric. We also report the scaled Brier score for each class (positive, negative, or neutral) separately and evaluated as a binary outcome against the other 2 classes.
SBS: scaled Brier Score.